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The Translesion DNA Polymerase z Plays a Major Role
in Ig and bcl-6 Somatic Hypermutation
bias in human Ig V(D)J and bcl-6 sequences (Chang and
Casali, 1994; Zan et al., 1999, 2000a).
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repairing a single-strand DNA gap (Bertocci et al., 1998;of Medical Sciences
Diaz and Flajnik, 1998; Storb et al., 1998b; Zan et al.,New York, New York 10021
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Knowledge of DNA synthesis and repair in eukaryotesSummary
has increased considerably, leading to the identification
of a dozen DNA polymerases. Pol a, d, and e are involvedIg somatic mutations would be introduced by a poly-
mainly in DNA replication and are expressed prevalentlymerase (pol) while repairing DNA outside main DNA
in the S phase of the cell cycle (Burgers, 1998). Pol greplication. We show that human B cells constitutively
specifically replicates mitochondrial DNA (Weissbach,express the translesion pol z, which effectively extends
1979), and pol u is restricted to DNA interstrand crosslinkDNA past mismatched bases (mispair extender), and
repair (Johnson et al., 2000a). Because of their special-pol h, which bypasses DNA lesions in an error-free
ized function, these DNA polymerases are unlikely to befashion. Upon B cell receptor (BCR) engagement and
involved in the hypermutation process. Pol b is essentialcoculture with activated CD41 T cells, these lympho-
for base excision repair and is error prone (Prasad etcytes upregulated pol z, downregulated pol h, and mu-
al., 1996; Sobol et al., 1996) but is not involved in hyper-tated the Ig and bcl-6 genes. Inhibition of the pol z
mutation, as immune-incompetent mice reconstitutedREV3 catalytic subunit by specific phosphorothioate-
with pol b-deficient fetal liver cells mutate their Ig genesmodified oligonucleotides impaired Ig and bcl-6 hyper-
normally upon antigenic challenge (Esposito et al.,mutation and UV damage-induced DNA mutagenesis,
2000b). Both pol z and pol h (Rad30A) are efficientwithout affecting cell cycle or viability. Thus, pol z plays
translesion polymerases (i.e., they carry out lesion by-a critical role in Ig and bcl-6 hypermutation, perhaps
pass DNA synthesis) and could be involved in hypermu-facilitated by the downregulation of pol h.
tation. Pol z is responsible for most damage-induced
and spontaneous DNA mutagenesis (mutagenic DNAIntroduction
repair) (Morrison et al., 1989; Lawrence and Hinkle, 1996;
Nelson et al., 1996; Holbeck and Strathern, 1997; Gibbs
Somatic hypermutation underlies the affinity maturation
et al., 1998, 2000; Lin et al., 1999; Murakumo et al., 2000),
of the antibody response (McKean et al., 1984; Ueki et and pol h is the defective polymerase in patients with
al., 1990; Ikematsu et al., 1993; Chang and Casali, 1994; the variant form of Xeroderma pigmentosum (XP-V)
Ikematsu et al., 1998; Neuberger et al., 1998). It targets (Johnson et al., 1999b; Masutani et al., 1999b). In spite
both the Ig and the bcl-6 loci and introduces single base of its highly distributive nature and intrinsic lack of proof-
substitutions, with rare deletions or insertions (Pasqua- reading capacity, pol h bypasses UV- and chemical-
lucci et al., 1998; Shen et al., 1998; Zan et al., 1999, 2000a). induced lesions by inserting deoxynucleotides mostly in
Somatic Ig and bcl-6 point mutations accumulate at a an error-free fashion in yeast, mouse, and human cells,
rate of 1023 to 1024 per base per cell generation and ex- as it favors the intervention of exogenous 39 ! 59 exo-
tend 1.5–2.0 kb downstream of the transcription initia- nucleases (Johnson et al., 1999a, 1999c, 2000c; Wash-
tion site, with preference for certain hot spots (Peters ington et al., 1999; Masutani et al., 1999a; Haracska et
and Storb, 1996; Fukita et al., 1998; Neuberger et al., al., 2000; Yamada et al., 2000).
1998; Shen et al., 1998; Storb et al., 1998a; Zan et al., As we (Diaz and Flajnik, 1998; Zan et al., 2000b) and
1999, 2000a). They favor transitions over transversions others (Papavasiliou and Schatz, 2000; Poltoratsky et
and display strand polarity, as inferred from the A over al., 2000) have suggested, the modalities of Ig and bcl-6
T bias in murine Ig gene V sequences (Smith et al., 1996; somatic mutations seem to best reflect the functional fea-
Neuberger et al., 1998; Storb et al., 1998a) and G over C tures of pol z (Papavasiliou and Schatz, 2000; Poltorat-
sky et al., 2000). This polymerase effectively extends DNA
past a lesion (mispair extender) with relative high fidelity,6 Correspondence: pcasali@med.cornell.edu
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possibly after the insertion of one or two mismatched nu- error-free translesion DNA synthesis, was expressed in
IgD1CD382 and slightly decreased in IgD2CD382 B cellscleotides by a low processivity, error-prone polymerase
(mispair inserter), such as the recently identified pol i but significantly downregulated in IgD1CD381 and
IgD2CD381 B cells. The lack of VHDJH-Cd transcripts in(Rad30B) (Tissier et al., 2000), pol k (Ohashi et al., 2000),
pol l (Aoufouchi et al., 2000; Garcia-Diaz et al., 2000), IgD2CD381 and IgD2CD382 lymphocytes confirmed the
(centroblastic and centrocytic) germinal center andor, perhaps, pol m (Aoufouchi et al., 2000; Dominguez
et al., 2000). Disruption of the pol z REV3 gene in mice memory phenotype, respectively, of these B cells, while
the comparable amounts of amplified CD79b andresults in early embryonic lethality (Bemark et al., 2000;
Esposito et al., 2000a). However, human fibroblasts in b-actin cDNA indicated that comparable numbers of
cells were analyzed for each fraction. The differentialwhich REV3 gene expression is inhibited by an antisense
REV3 fragment display impaired damage-induced muta- expression of DNA pol z and pol h in the tonsillar B cell
subsets was emphasized by the amplification of thesegenesis but normal growth (Gibbs et al., 1998). We there-
fore addressed the role of pol z in hypermutation using polymerases in the same vessel, together with b-actin
(Figure 1), and was confirmed by multiple RT-PCRs us-human B cells in vitro. In this study, we show that pol z
plays a critical role in hypermutation, as indicated by ing serially diluted cDNAs (see Supplemental Figure S1
at http://www.immunity.com/cgi/content/full/14/5/645/the significant reduction of somatic Ig and bcl-6 hyper-
mutation in B cells in which pol z mRNA transcripts were DC1) (data not shown). These ex vivo experiments show
that human tonsillar IgD1CD381 and IgD2CD381 B cells,inhibited by specific oligonucleotides. We also show
that pol z is upregulated by B cell receptor (BCR) en- which undergo intensive Ig hypermutation in response
to antigen binding and T cell help, display a significantgagement, which simultaneously downregulates pol h,
thereby making pol z mispair extender activity abun- alteration of the expression of the translesion DNA pol z
and pol h.dantly available to possibly mutate Ig and bcl-6 DNA.
Results BCR Induces Upregulation of pol z, Downregulation
of pol h, and Ig VHDJH Hypermutation
As we have shown in human IgM1IgD1 B cells, contactPol z Is Upregulated and pol h Is Downregulated
in Mutating Human B Cells with activated CD41 T cells is sufficient to induce Ig
class switching and germinal center-like differentiationIg V(D)J and bcl-6 hypermutation occurs in germinal cen-
ters of secondary lymphoid organs, such as tonsils and (Zan et al., 1998; Cerutti et al., 1998a, 1998b, 2000; Schaf-
fer et al., 1999), but induction of somatic hypermutationlymph nodes, during the transition from IgD1CD382 naive
B cell to IgD1CD381 early centroblast and IgD2CD381 requires BCR engagement (Zan et al., 1999, 2000a). We
hypothesized that the pol z and pol h up- and downregu-full-blown centroblast, with some IgD1CD381 B cells
displaying an uncommonly high frequency of somatic lation found in mutating B cells was induced by the
antigen-mediated crosslinking of the BCR on these ger-mutations, possibly as a result of the sequestration of
this subpopulation in the germinal center environment minal center lymphocytes. We used our human mono-
clonal CL-01 B cell line to prove that BCR engagement(Pascual et al., 1994; Liu et al., 1996; Wilson et al., 2000).
In human tonsils, highly mutated V(D)J and bcl-6 DNA modulates pol z and pol h levels and that this DNA
polymerase modulation is associated with somatic hy-sequences are found in CD381 germinal center and CD382
memory but not in CD382 naive B cells (Pascual et al., permutation. CL-01 B cells are IgM1IgD1 and, upon en-
gagement of BCR and contact with activated CD411994; Liu et al., 1996; Pasqualucci et al., 1998; Shen et
al., 1998; Wilson et al., 2000). T cells, undergo Ig class switching and effectively mu-
tate the Ig V(D)J and bcl-6 genes at a rate and withTo analyze the involvement of DNA polymerases in
somatic hypermutation, we sorted tonsillar B lymphocytes modalities that mimic those of B cells in vivo (Zan et
al., 1999, 2000a). In these B cells, BCR engagementinto IgD1CD382 (naive B cells), IgD1CD381 (early centro-
blasts), IgD2CD381 (germinal center centroblasts and cen- increased the expression of the pol z REV3 catalytic
subunit while virtually ablating pol h expression and,trocytes), and IgD2CD382 (memory B cells) fractions and
measured the expression of DNA pol z REV3 and pol h together with activated CD41 T cells, induced Ig VHDJH
gene hypermutation (28 nucleotide changes in 112.5 kb(RAD30A), as well as pol i (RAD30B), pol a, pol b, pol d,
pol e, pol k, and pol m by RT-PCR (Figure 1). The sizes of analyzed) (Figure 2). No alteration in the expression of
pol z and pol h and no hypermutation occurred in similarall amplified cDNAs were as predicted, and, in each case,
the cDNA was cloned and found to contain the correct B cells cultured with activated CD41 T cells without BCR
engagement (two changes in 94 kb) or cultured with nil,coding sequence (data not shown). Pol a, pol b, pol d,
pol e, and the error-prone pol i and pol k were expressed at with (two changes in 75 kb) or without (one change in
56 kb) reaction with anti-BCR Ab. Consistent with ourcomparable levels in IgD1CD382, IgD1CD381, IgD2CD381,
and IgD2CD382 B cells. In contrast, the gene encoding previous findings (Zan et al., 1999, 2000a, 2000b), the
B cells cultured with activated CD41 T cells without BCRthe catalytic subunit of the translesion pol z REV3 was
expressed at significantly higher levels in the mutating engagement underwent Ig class switching and germinal
center phenotypic differentiation (data not shown). TheIgD1CD381 and IgD2CD381 B cells than in the nonmu-
tating IgD1CD382 and IgD2CD382 B cells (Pascual et al., specificity of the reciprocal modulation of DNA pol z and
pol h was further emphasized by the relatively constant1994; Liu et al., 1996; Shen et al., 1998; Wilson et al., 2000).
Theerror-pronepolm was equallyexpressed in IgD1CD382, levels of pol i, pol a, pol b, pol d, pol e, and pol m in
B cells reacted or not reacted with anti-BCR Ab andIgD2CD381, and IgD2CD382 B cells but slightly upregu-
lated in IgD1CD381 cells. Pol h, which can perform cultured with or without activated CD41 T cells, as well
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Figure 1. Somatic Hypermutating Human Tonsillar B Cells Upregulate DNA pol z and Downregulate pol h
Mutating IgD1CD381 early centroblasts (EC) and IgD2CD381 centroblasts/centrocytes (CC) and unmutating IgD1CD382 naive (N) and
IgD2CD382 memory (M) B cells were isolated from human tonsillar B cells and analyzed for the expression of pol z REV3, pol h (RAD30A),
pol i (RAD30B), pol a, pol b, pol d, pol e, pol k, and pol m, using RT-PCR. Pol z, pol h, and b-actin were amplified in the same vessel. These
findings were derived from one of three experiments yielding comparable results.
as by further analysis involving multiple RT-PCRs using Specific Inhibition of pol z Impairs Ig VHDJH and bcl-6
Somatic Hypermutation and Damage-Induced DNAserially diluted cDNAs (data not shown). These in vitro
Mutagenesis in Human B Cellsexperiments show that BCR engagement effectively
We used specific phosphorothioate oligonucleotides tomodulates pol z and pol h expression and induces Ig
inhibit the pol z REV3 catalytic subunit in human B cellshypermutation in a fashion that is consistent with the
induced by activated CD41 T cells upon BCR engage-findings in ex vivo tonsillar B cells.
ment. The oligonucleotides were introduced into CL-01
cells, using the cationic lipid Cytofectin GSV (Lewis et
BCR-Induced pol z and pol h Regulation Is Dose al., 1996), which in our hands has yielded consistently
and Time Dependent more than 85% transfection efficiency, at a final concen-
To assess the specificity of the BCR-induced modula- tration of 2 mM, starting at day 21 (a day prior to stimula-
tion of DNA polymerase expression, we treated human tion with anti-BCR Ab and activated CD41 T cells) and
CL-01 IgM1IgD1 B cells with increasing amounts of anti- every day thereafter. Pol z REV3 catalytic subunit, pol h,
BCR Ab and measured by RT-PCR the levels of pol z, pol i, pol a, pol b, and pol m transcripts were determined
pol h, pol i, pol a, pol d, pol e, pol k, and pol m in these by specific RT-PCR at days 1, 2, 5, 7, 9, and 14 of culture;
cells after 12 hr of culture (Figure 3). Consistent with the mutated Ig VHDJH and bcl-6 transcripts were analyzed
results of the ex vivo and in vitro experiments (Figures 1 after 14 days of culture, as in the experiments of Figure 2.
and 2), these DNA polymerases were all constitutively REV3 transcripts were significantly reduced by the spe-
expressed in the B cells (Figures 3A and 3B). Pol z REV3 cific sense S01 and antisense AS01 but not the scram-
was upregulated in a dose-dependent fashion by BCR bled (SCRA) or the antisense AS02 and AS03 oligonucle-
engagement, which induced a concomitant downregu- otides, as early as 36 hr after the initiation of the culture,
lation of pol h but no significant changes in pol i, pol a, and remained such throughout day 14 (Figure 4A and data
pol d, pol e, pol k, and pol m. The reciprocal modulation not shown). None of the oligonucleotides inhibited pol i,
of pol z and pol h began as early as 1 hr after BCR en- pol a, pol b, or pol m expression. The pol z inhibition
gagement, peaked within 9–24 hr, and lasted as long as was confirmed by multiple RT-PCRs, using different
48 hr after a single treatment of B cells with anti-BCR numbers of cycles and serially diluted cDNAs (Supple-
Ab (Figure 3C). It was reproduced in freshly isolated mental Figure S1 and data not shown). An overall com-
normal human IgM1IgD1 B cells (Figure 3D) and con- parable pattern of DNA polymerase modulations was
firmed by multiple RT-PCRs using serially diluted cDNAs observed in B cells cultured in the absence of activated
(Supplemental Figure S1 and data not shown). It was CD41 T cells and without BCR engagement (Figure 4B).
not due to lymphocyte proliferation or differentiation, as The reduced pol z expression resulted in impaired Ig
indicated by the demonstration that CD154 or activated VHDJH and bcl-6 hypermutation. As we have shown (Zan
CD41 T cells, which provide strong B cell proliferation et al., 2000a), bcl-6 mutates in response to the same
and differentiation stimuli, did not influence the expres- stimuli and with the same modalities as Ig V(D)J genes.
sion of pol z, pol h, pol i, pol a, pol d, pol e, pol k, or As determined by single-strand DNA conformation poly-
pol m in the absence of BCR engagement (Figure 2 and morphism (SSCP) analysis, CL-01 cells cocultured, upon
data not shown). Finally, consistent with the lack of BCR engagement, with activated CD41 T cells for 14 days
hypermutation in T cells (Bachl and Wabl, 1995), TCR with daily treatment of the scrambled (SCRA) oligonucle-
complex crosslinking by an anti-CD3 Ab did not modu- otide, and Cytofectin GSV mutated as many as 12.31%
late the expression of pol z or pol h in freshly isolated and 9.62% of the 375 bp Ig VHDJH, and the 226 bp bcl-6
Exon I cDNA segments (Table 1), yielding a frequencynormal human T cells (Figure 3E).
Immunity
646
ation, as these parameters were not significantly af-
fected by Cytofectin GSV alone and/or the different
phosphorothioate-modified oligonucleotides through-
out the culture period (Figures 5A and 5B) but was asso-
ciated with an impairment of the B cells to copy the
UV-damaged shuttle pSP189 vector DNA (Figure 4D),
a mutagenic function that reflects pol z Rev3 activity
(Morrison et al., 1989; Lawrence and Hinkle, 1996; Nel-
son et al., 1996; Holbeck and Strathern, 1997; Gibbs et
al., 1998, 2000; Lin et al., 1999; Murakumo et al., 2000),
and increased cell death by UV light (data not shown).
The Residual Ig VHDJH and bcl-6 Mutations Found after
Inhibition of pol z Do Not Differ from Those Introduced
in the Presence of pol z
The residual Ig VHDJH and bcl-6 mutations in the CL-01
cells induced by activated CD41 T cells upon BCR-
engagement and treated with the REV3-specific oligo-
nucleotides displayed features similar to those found in
the CL-01 cells similarly induced but treated with the
SCRA oligonucleotide or Cytofectin GSV alone. The 56
Ig VHDJH and 23 bcl-6 exon 1 mutated cDNA clones
from the induced CL-01 cells treated with the SCRA
oligonucleotide (Table 1) bore 58 and 27 independent
point mutations, respectively (Table 2). Of the total 85
point mutations, 55 (65%) were transitions, while ran-
domly occurring point mutations would be expected to
be one-third transitions and two-thirds transversions.
G nucleotides were mutated (49.4% of the total point
mutations) at a frequency 68% higher than expected by
chance alone (29.4%), after correcting for base compo-
sition, with G ! A transitions accounting for 69.0% of
the total G mutations and 52.7% of all transitions. The
residual 26 Ig VHDJH and 16 bcl-6 exon 1 mutated cDNA
clones from the induced CL-01 cells treated with the
Figure 2. Upregulation of pol z and Downregulation of pol h Are In- REV3-specific S01 and AS01 oligonucleotides (Table 1)
duced by BCR Engagement and Are Associated with Somatic Hy-
bore 26 and 17 independent point mutations, respec-permutation
tively (Table 2). Of the total 43 point mutations, 29Human IgM1IgD1 CL-01 cells were cultured in the presence or ab-
(67.2%) were transitions. G nucleotides were mutatedsence of activated CD41 T cells with or without treatment with anti-
at a frequency (51.2% of the total point mutations) 74.2%BCR Ab. After 12 hr, 1, 2, 5, 7, and 9 days, 0.5 3 106 B cells from each
culture were harvested. RNA was extracted and used to analyze the higher than that expected by chance alone (29.4%), after
expression level of pol z REV3, pol h, pol i, pol a, pol b, pol d, pol e, correcting for base composition, with G ! A transitions
and pol m by RT-PCR. Shown are the levels of the DNA polymerases accounting for 77.3% of the total G mutations and 58.6%
after 12 hr of culture. Comparable levels were detected at day 1, 2,
of all transitions.5, 7, and 9. After 14 days, the cultures were terminated to identify
and analyze the Ig VHDJH mutated transcripts. Histograms depict
the findings derived from one of three independent experiments Discussion
yielding comparable results.
As we showed, the induction of Ig and bcl-6 hypermuta-
tion (Zan et al., 1999, 2000a) but not that of class switch
DNA recombination (Zan et al., 1998; Cerutti et al.,of mutations of 3.28 3 1024 and 4.25 3 1024 change/base,
respectively (Figure 4C). This frequency was compara- 1998a, 1998b, 2000; Schaffer et al., 1999) requires, in
addition to CD41 T cell help, BCR engagement, therebyble to that of similarly induced CL-01 cells treated with
Cytofectin GSV alone (nil), AS02, or AS03. In contrast, indicating that the function of the BCR goes beyond
providing the structural correlate for the selection ofCL-01 cells stimulated with anti-BCR Ab and activated
CD41 T cells but treated daily with the pol z REV3- higher affinity mutants. We show here that, in B cells,
the expression of the translesion pol z is effectively mod-specific S01 or AS01 oligonucleotide and Cytofectin
GSV mutated as few as 3.34% and 3.14% of the ex- ulated by BCR engagement and that the inhibition of
this polymerase by specific oligonucleotides impairs Igpressed Ig VHDJH and bcl-6 transcripts, respectively,
which corresponded to about 73% reduction (p , 0.001) VHDJH and bcl-6 hypermutation and, to a comparable
extent, DNA damage-induced mutagenesis without af-in mutation frequency, as compared to CL-01 cells
treated with SCRA, AS02, or AS03 or Cytofectin GSV fecting cell cycle or growth. Thus, in human B cells,
pol z is regulated by the BCR and plays a critical rolealone. This decrease in Ig and bcl-6 mutation frequency
was not due to changes in cell cycle, viability, or prolifer- in somatic hypermutation, perhaps facilitated by pol h
DNA Polymerase z in B Cell Hypermutation
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Figure 3. Pol z Is Upregulated and pol h Is Downregulated by BCR but Not TCR in a Dose- and Time-Dependent Fashion in Human Lymphocytes
(A) Human CL-01 cells were reacted with increasing amounts of anti-BCR Ab for 1 hr at 48C, washed, and cultured in FCS-RPMI for 12 hr.
The level of pol z REV3, pol h, pol i, pol a, pol b, pol d, pol e, and pol m was measured by RT-PCR for each anti-BCR Ab concentration.
(B) Level of pol z REV3, pol h, and b-actin in the same B cells as in (A), as determined by single-vessel RT-PCR incorporating [a-32P]dCTP
and consisting of 10, 15, or 25 cycles.
(C) Human CL-01 cells were reacted with anti-BCR Ab, washed, and cultured in FCS-RPMI. The level of pol z, pol h, and pol i was measured
at 1, 3, 6, 9, 24, and 48 hr.
(D) Freshly isolated normal human peripheral blood IgM1IgD1 B cells were reacted with anti-BCR Ab (1 mg/ml) for 1 hr at 48C, washed, and
cultured in FCS-RPMI for 12 hr before analysis of pol z, pol h, and pol i transcripts.
(E) Normal human CD41 normal T cells were cultured in FCS-RPMI in flat-bottom 96-well culture plates coated with 1:800 OKT3 anti-CD3 Ab
for 12 hr and then analyzed for pol z, pol h, and pol i transcripts.
downregulation, which is also BCR dependent. The but not in IgD1CD382 naive B cells, which express un-
mutated Ig V(D)J and bcl-6 genes, and in IgD2CD382modulation of the expression of these polymerases may
be regulated not only at the transcriptional but also the memory B cells, which express mutated Ig V(D)J and
bcl-6 genes, but in which the hypermutation process isposttranscriptional level.
B cells initiate somatic hypermutation upon exposure extinct (Figure 1). The demonstration that BCR engage-
ment increases pol z and decreases pol h but does notto antigen and activated CD41 T cells in germinal centers
of secondary lymphoid organs. The demonstration that lead to somatic hypermutation unless activated T cells
are also present (Figure 2) suggests that accessibilityBCR engagement signals in a dose-dependent fashion
the upregulation of pol z with concomitant downregula- of the hypermutation machinery to the Ig and bcl-6 loci
is important and likely requires multiple signals.tion of pol h, while inducing Ig and bcl-6 hypermutation,
is highly consistent with the findings in tonsillar B cells: Our experiments show that pol z, which is essential
for DNA damage-induced mutagenesis (Morrison et al.,pol z was upregulated and pol h downregulated in
IgD1CD381 and IgD2CD381 B cells, which include the 1989; Lawrence and Hinkle, 1996; Nelson et al., 1996;
Holbeck and Strathern, 1997; Gibbs et al., 1998, 2000;majority of the highly hypermutating B lymphocytes
(Pascual et al., 1994; Liu et al., 1996; Wilson et al., 2000), Lin et al., 1999; Murakumo et al., 2000), is also critical
Immunity
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Figure 4. Specific Inhibition of pol z REV3 Expression Impairs Ig VHDJH and bcl-6 Somatic Hypermutation as well as Damage-Induced DNA
Mutagenesis in CL-01 Cells Induced by BCR Engagement and Contact with Activated CD41 T Cells
(A) Human B cells cocultured with activated CD41 T cells upon BCR engagement after daily treatment with Cytofectin GSV only (Nil) or
Cytofectin GSV together with the specific pol z REV3 S01, AS01, AS02, AS03, or SCRA control oligonucleotide, from day 21 to day 13. B cells
were harvested at days 1, 2, 5, 7, 9, and 14 by positive selection with a biotinylated anti-CD19 mAb and MiniMac System Streptavidin
microbeads (Miltenyi Biotec, Inc.) for RNA extraction. Shown are the transcript levels of pol z REV3, pol h, pol i, pol a, pol b, and pol m, as
measured by RT-PCR after 9 days of cultures (comparable pol z inhibition was observed at all other time points analyzed). These findings
were derived from one of three independent experiments yielding comparable results (data are from the experiments of Table 1).
(B) Specific pol z REV3 oligonucleotides selectively inhibit the expression of pol z REV3 in CL-01 cells cultured in the absence of activated
CD41 T cells and without prior BCR engagement. All other experimental conditions and analyses are as in (A).
(C and D) Frequency of the mutations in the Ig VHDJH and bcl-6 transcripts in the B cells from the cultures of (A).
(E) CL-01 cells were treated with Cytofectin GSV only or Cytofectin GSV together with the pol z REV3 S01, AS01, SCRA, AS02, or AS03
oligonucleotides and then analyzed for the damage-induced mutagenesis using the UV-treated pSP189 shuttle vector. Histograms depict the
frequency of 6-thioguanine-resistant mutants (white colonies out of about 4000 total colonies for each treatment).
for the hypermutation of both the Ig and bcl-6 loci in “mispair extender.” The central role of pol z in damage-
induced mutagenesis would be reflected in the centralhuman B cells. In spite of the lack of 39 ! 59 exonuclease
activity, pol z copies with high fidelity undamaged DNA role of this polymerase in hypermutation. In Saccharo-
myces cerevisiae, pol z has been shown to be involvedtemplate (Johnson et al., 2000b). It is very inefficient in
inserting deoxynucleotides opposite DNA lesions but in the generation of most mutations associated with
transcription (Datta and Jinks-Robertson, 1995) and, byreadily extends from such nucleotides once they have
been inserted. Indeed, it extends damaged DNA effi- engaging sites near DNA breaks, to increase the fre-
quency of base substitutions in the vicinity of breaks byciently, in concert with the error-prone, low processivity
pol i, after the incorporation of one or two mismatched at least 100-fold (Strathern et al., 1995; Holbeck and
Strathern, 1997). Both transcription and DNA breaksdeoxynucleotides opposite DNA lesions by this poly-
merase (Johnson et al., 2000b). Pol i and pol z act se- would be involved in the B cell somatic hypermutation
process.quentially: pol i as a “mispair inserter” and pol z as
DNA Polymerase z in B Cell Hypermutation
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Table 1. Inhibition of Polymerase z (REV3) Expression Reduces Ig VHDJH and bcl-6 Somatic Hypermutation
NIL SCRA S01 AS01 AS02 AS03
Transcripts VHDJH bcl-6 VHDJH bcl-6 VHDJH bcl-6 VHDJH bcl-6 VHDJH bcl-6 VHDJH bcl-6
Experiment 1
Analyzed 128 ND 109 ND 108 ND ND ND ND ND ND ND
Mutated 14 ND 13 ND 3 ND ND ND ND ND ND ND
Experiment 2
Analyzed 202 112 101 120 131 112 124 112 103 102 100 102
Mutated 31 12 15 12 6 4 8 4 10 9 10 9
Experiment 3
Analyzed 109 185 245 119 150 143 137 118 100 102 101 100
Mutated 12 17 28 11 4 4 5 4 11 11 11 10
Total
Analyzed 439 297 455 239 389 255 261 230 203 204 201 202
Mutated 57 29 56 23 13 8 13 8 21 20 21 19
Mutated (%) 12.98 9.76 12.31 9.62 3.34 3.14 4.98 3.48 10.34 9.80 10.45 9.41
ND, not done; SCRA, scambled; S, sense; AS, antisense.
The meaning of the BCR-induced downregulation of prone) polymerase, such as pol i or pol m, which would
then lead to the extension of the mutated DNA by thepol h in human hypermutating B cells in vivo (Figure 1)
and in vitro (Figures 2 and 4) is unclear. Pol h lacks mispair extender pol z. Both pol i and pol m have been
suggested to be preferentially expressed in secondaryproofreading 39 ! 59 exonuclease activity, but its low
processivity allows for extrinsic exonucleases to proof- lymphoid tissues (Aoufouchi et al., 2000; Dominguez et
al., 2000; Poltoratsky et al., 2000). Neither was downreg-read the mismatched nucleotides it inserts (Bebenek et
al., 2001). This, together with the inability of pol h to ulated by BCR engagement in vivo (Figure 1) or in vitro
(Figures 2–4).elongate a DNA chain after incorporating the incorrect
nucleotide opposite a lesion, allows this polymerase The involvement of pol z in the somatic hypermutation
process was demonstrated using specific sense andto perform error-free translesion synthesis of damaged
DNA (Johnson et al., 1999a, 1999a, 1999b, 2000a; Wash- antisense phosphorothioate-modified oligonucleotides,
which effectively inhibited the expression of the REV3ington et al., 1999; Masutani et al., 2000; Matsuda et al.,
2000). Our demonstration that BCR engagement upreg- gene without altering the expression of pol i, pol a, pol b,
pol m, or b-actin (Figures 4A and 4B). The ability of S01ulates pol z and profoundly downregulates pol h sup-
ports the speculation that the lack or scarcity of pol h and AS01 but not AS02 and AS03 to actually inhibit pol z
expression was highly consistent with the degree offacilitates the insertion of mismatched nucleotides (mu-
tations) at the site of DNA breaks by another (error- effectiveness predicted for these oligonucleotides using
Figure 5. Cytofectin GSV and the pol z REV3 Phosphorothioate Oligonucleotides Do Not Significantly Affect B Cell Cycle or Proliferation
(A) CD191 cells from CL-01 cultures (same or similar to those of Figure 4) treated daily with Nil, Cytofectin GSV only, and Cytofectin GSV
together with the SCRA, S01, or AS01 oligonucleotides, respectively, were harvested for counting and analysis of viability at days 0, 1, 2, 5,
7, 9, and 14 of culture. More than 90% of the B cells were viable at any time point.
(B) B cell (from [A]) cycle analysis by PI staining at days 0, 2, 7, 9, and 14 of culture.
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Table 2. Nature of the Base Substitutions in the Ig VHDJH and bcl-6 cantly affected UV-induced mutagenesis but not cell
Genes of Induced CL-01 Cells Transfected by DNA Polymerase z division (Gibbs et al., 1998). The residual damage-induced
(REV3)-Scrambled Oligonucleotides mutagenic activity measured in the B cells treated with
B Cells Transfected by DNA Polymerase z (REV3)-Scrambled S01 and AS01 was consistent with the residual mutations
Oligonucleotide detected in the Ig VHDJH and bcl-6 genes of the same
cells (Figures 4C and 4D).Transitions G ! C A ! G C ! T T ! C
55 29a 5 17 4 Recently, a potential RNA editing enzyme activation-
[28.3] [8.3]b [6.8] [6.8] [6.2] induced (cytidine) deaminase (AID) has been found to
play a crucial role in class switching and Ig somaticTransversions G ! C A ! T C ! A T ! A
11 5 1 4 1 hypermutation (Muramatsu et al., 2000; Revy et al.,
[28.3] [8.2] [6.8] 6.8] [6.2] 2000). In AID-deficient mice and patients with defective
G ! T A ! T C ! G T ! G AID function, Ig somatic hypermutation appears to be
19 8 5 0 6 defective (Muramatsu et al., 2000; Revy et al., 2000), but
[28.3] [8.3] [6.8] [6.8] [6.2]
the role of AID in the somatic hypermutation process in
Total Mutations G ! N A ! N C ! N T ! N unclear and possibly indirect. The most likely targets
85 42d 11d 21 11c for AID could be any of the DNA enzymes that would
[85] [25.0] [20.5] [20.5] [18.7]
be involved in somatic hypermutation, including pol z
B Cells Transfected by DNA Polymerase z (REV3)-Specific and perhaps an endonuclease that creates a single-
Oligonucleotide strand nick or a double-strand cut. Thus, pol z and AID
Transitions G ! A A ! G C ! T T ! C would represent different elements with different func-
29 17 2 7 3 tions in the somatic hypermutation process, which
[14.3] [4.2] [3.5] [3.5] [3.2] would also include, as suggested by our experiments,
a role for the modulation of pol h. Whether pol h overex-Transversions G ! C A ! C C ! A T ! A
7 2 2 2 1 pression affects Ig somatic hypermutation and whether
[14.3] [4.2] [3.5] [3.5] [3.2] AID expression is, like pol z and pol h, under the control
G ! T A ! T C ! G T ! G of signals emanating from the BCR is currently being
7 3 0 1 3
investigated in our laboratory.[14.3] [4.2] [3.5] [3.5] [3.2]
Total Mutations G ! N A ! N C ! N T ! N Experimental Procedures
43 22d 4d 10 7
[43] [12.6] [10.5] [10.4] [9.5] Lymphocytes
The phenotypic and functional features of the human monoclonala Identical mutations in different gene segments of the given region
IgM1IgD1 CL-01 B cell line were reported (Zan et al., 1998, 1999,were assumed not to be independent and were counted only once.
2000a; Cerutti et al., 1998a, 1998b, 2000; Schaffer et al., 1999). To pre-b The expected number of mutations (from a given nucleotide resi-
pare sIgD1 B cells, human PBMCs were depleted of T cells (Ceruttidue to another given nucleotide residue) was normalized for the base
et al., 1998b), reacted with a mouse mAb to human IgD (Southerncomposition of the unmutated Ig VHDJH and bcl-6 gene sequences Biotechnology Associates, Inc.), and then with magnetic Microbeads(unstimulated CL-01 cells). It was calculated by multiplying the fre-
conjugated with goat anti-mouse IgG (Miltenyi Biotec, Inc.). The Mi-quency of occurrence of the nucleotide target of mutated sequence
crobead-treated sIgD1 B cells were separated using a MACS mag-by the total number of observed mutations and dividing the product
netic sorter (Miltenyi Biotec, Inc.). Tonsillar IgD1CD382, IgD1CD381,by three.
IgD2CD381, and IgD2CD382 B cells were selected upon incubationc p , 0.05.
of purified IgD1 B cells with MultiSort Release Reagent (Miltenyid p , 0.001.
Biotec, Inc.), FITC-conjugated mouse mAb to CD38 (PharMingen),
and anti-FITC MicroBeads (Miltenyi Biotec, Inc.), as reported (Cerutti
et al., 2000). The homogeneity of the separated cell fractions was
assessed using a FACScalibur (Becton Dickinson). The human acti-
the HYBsimulator (RNAture, Inc.). Antisense oligonucle- vated CD41 T cells used for the hypermutation induction experi-
ments were prepared as reported (Zan et al., 1999, 2000a).otides would disrupt gene expression by providing a sub-
strate for RNase H upon hybridization with mRNA (Ge-
Human DNA pol z, pol h, pol i, pol a, pol b, pol d, pol e, pol k,wirtz et al., 1998); sense oligonucleotides would impair
and pol m Transcriptsgene transcription by hybridizing with double-strand
The level of pol z, pol h (RAD30A), pol i (RAD30B), pol a, pol b,
DNA, within the major helix groove, to generate a triple- pol d, pol e, pol k, and pol m was analyzed by RT-PCR. This was
stranded molecule, thereby preventing duplex unwinding made semiquantitative by performing dilution analysis so that there
was a linear relationship between the amount of cDNA used and(Chan and Glazer, 1997; Gewirtz et al., 1998; Praseuth et
the intensity of the PCR product. Each PCR consisted of 25 cycles,al., 1999; Catapano et al., 2000; Faria et al., 2000).
each of 1 min denaturation at 948C, 1 min annealing at 608C, andThe impairment of UV-induced DNA mutagenesis, as
1 min extension at 728C. The amplifications were completed by anassessed using the pSP189 shuttle vector (Figure 4E),
additional 10 min extension at 728C. RT-PCR using [a-32P]dCTP
in the human B cells treated with the pol z REV3 S01 consisted of 10, 15, and 25 cycles. RNA was extracted from 2 3
and AS01 but not the SCRA, AS02, or the AS03 phospho- 106 B cells, using the RNeasy Mini Kit (Qiagen, Inc.). The first-strand
cDNAs were synthesized from equal amounts of total RNAs (4 mg),rothioate-modified oligonucleodites strengthened our
using the SuperScript Preamplification System (Life Technologies,findings on Ig and bcl-6 hypermutation. The normal cell
Inc.). The different cDNAs were amplified using the same amountcycle, viability, and proliferation of the human B cells in
of first-strand cDNA template together with the following specificwhich pol z REV3 transcripts were inhibited by the spe-
primers: pol z REV3, 59-GAGATTCAGATGCATTCCTGG-39 (forward),
cific oligonucleotides was evocative of the findings in 59-GTCTTGCTTGTAAGCCTTCAT-39 (reverse), or 59-GTTGCTTTGAT
human MSU-1.2-10A-42 fibroblasts, in which the ex- CGACACATCCC-39 (for2), 59-GAGGTTTTCAGTGCTCCTTCCAC-39
(rev), 59-ATGTGGACATCCTGCTCATCCG-39 (rev2); pol h, 59-CGAApression of a high level of antisense REV3 mRNA signifi-
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ATGATAATGACAGGGTAGCC-39 (for), 59-GGAGCAGTAAGAGATGA oligonucleotides/Cytofectin GSV mixture was supplemented with
FCS-RPMI to yield a total volume of 2.5 ml. The resulting mixtureAAGCGAAG-39 (rev); pol i, 59-TTGCTTTAGGGCTCAAGGGTG-39 (for),
59-TTCACATAAGTAAGGCTGGCGG-39 (rev); pol a, 59-AAGCACATC was then added to 0.5 3 106 CL-01 cells in a flat-bottom 6-well plate
which was incubated for 24 hr at 378C. After incubation, the B cellsTTGACCCAGAGGAGC-39 (for), 59-CAGAGAACAGCAGAGGACAGA
AGC-39 (rev); pol b, 59-AAGATTCGGCAGGATGATACGAG-39 (for), were reacted with anti-BCR Ab and then cocultured with CD41 T
cells for a cycle of 14 days, as outlined above, with the oligonucleo-59-AACACCCATGAACTTTGTCTCACC-39 (rev); pol d, 59-GCCAGCAG
GTCAAAGTCGTATC-39 (for), 59-GCACTGAGGTCTTCACAAACTCG-39 tides/Cytofectin GSV treatment being repeated every 24 hr. B cells
were purified after 1, 2, 5, 7, 9, and 14 days by positive selection(rev); pol e, 59-GATGAGGAGGAAAGAGATGGGG-39 (for), 59-GGGTT
ATTGAGCAGCAAGTGGG-39 (rev); pol k, 59-TTGCTTTAGGGCTCAA with a biotinylated anti-CD19 mAb and MiniMac System Streptavidin
microbeads (Miltenyi Biotec, Inc.) for the the analysis of the DNAGGGTG-39 (for), 59-TTCACATAAGTAAGGCTGGCGG-39 (rev); pol m,
59-GCCTGTTCTCAGCACAATGTCTC-39 (for), 59-GTCTGGGAAATC polymerases and the Ig VHDJH and bcl-6 transcripts. At the same
time points, the same and similar cultures were analyzed for cellCTCGCCTAAC-39 (rev). In selected experiments, RT-PCR for pol z
REV3, pol h, and b-actin were performed in the same vessel. number, viability (trypan blue exclusion), and cycle, using propidium
iodide (PI) and fluorescence flow cytometry (Noguchi, 1992).
Damage-induced DNA mutagenesis was analyzed essentially asInduction of Somatic Hypermutation in Human B Cells
reported by Seidman (Seidman, 1996). In brief, CL-01 cells wereTo induce Ig hypermutation, human IgM1IgD1 CL-01 B cells (0.5 3
treated with Cytofectin GSV only or with Cytofectin GSV and the106) were reacted for 1 hr at 48C with IMMUNOBEAD-conjugated
pol z REV3 S01, AS01, SCRA, AS02, and AS03 oligonucleotides dailyrabbit Ab to human Ig m chain and rabbit Ab to human Ig (H 1 L
for 3 days and transfected with the UV-irradiated (500 J/m2) pSP189chain) (Irvine Scientific) (mixed 1:1 at 1 mg/ml) (anti-BCR Ab), and
shuttle vector on day 4. After 2 more days of culture, the plasmidthen washed with cold PBS before being placed in culture with
DNA was recovered, digested with Dpn I, and used to transform E.activated CD41 T cells. The activated CD41 T cells were used at
Coli MBM 7070 test strain. The frequency of white (mutated) coloniesleast 2 weeks from the last stimulation and were incubated for 6
was taken as measure of B cell mutagenic activity.hr with 20 ng/ml of 13-phorbol 12-myristate acetate (PMA) (Sigma
Chemical Co.) and 500 ng/ml of ionomycin (Calbiochem-Novabio-
Acknowledgmentschem Co.) prior to coculture with B cells (Zan et al., 1999, 2000a).
B cells were cocultured in the presence of 2.5 3 106 irradiated and
We are grateful to Dr. William K. Holloman for helpful discussionsactivated CD41 T cells or nil in a flat-bottom 6-well (5.0 ml FCS-
and to Dr. Michael M. Seidman for the shuttle vector pSP189 andRPMI volume) plate. After 7 days of culture during which fresh anti-
the test E. Coli strain MBM7070. We thank Shefali Shah and PatBCR Ab was added every other day at a final concentration of 0.1 mg/
Dramitinos for their excellent technical assistance. This work wasml, the lymphocytes were washed in fresh FCS-RPMI and then
supported by the National Institutes of Health grants AR 40908,supplemented with freshly activated CD41 T cells. After additional
AG 13910, and AI 45011 and by a Research Grant from the SLE7 days of similar treatment, the cultures were terminated. At 12 hr,
Foundation, Inc. (New York) (to P.C.). A.S. was supported by a Can-1 day, 2, 5, 7, 9, and 14 days from the initiation of the culture, the
cer Research Institute (New York) fellowship.B cells were purified by positive selection with a biotinylated anti-
CD19 mAb and MiniMac System Streptavidin microbeads (Miltenyi
Biotec, Inc.) and used as a source of mRNA for the analysis of DNA Received October 17, 2000; revised April 10, 2001.
polymerases and Ig V(D)J and bcl-6 mutations.
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